Similar Items: Pharmacokinetics of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in pediatric patients with primary immunodeficiency disease
- Precision Prediction of Pediatric Subcutaneous Immunotherapy Outcomes Using a Clinical Nomogram for House Dust Mite Allergy
- A Novel Variant of CORO1A Gene Contributing to the Development of Primary Immunodeficiency in Children
- Persistence and Reasons for Discontinuation of Subcutaneous Immunotherapy in Children with Dust Mite Allergy: A Real-World Cohort from Hangzhou, China
- Spectrum of Pathogens Isolated from Patients with Hemolytic Diseases
- The Effects of Alternate-Day Corticosteroids in Autoimmune Disease Patients
- In-Hospital Outcomes and Mortality of Pediatric Asthma Exacerbations in Thailand: A Nationwide Study (2015–2022)